Yahoo Finance • 8 days ago

CellCarta Establishes Strategic Partnership with Waters to Advance Companion Diagnostics Development

Collaboration combines CellCarta's global clinical trial testing capabilities with Waters' standardized flow cytometry platforms and expertise MONTREAL, Oct. 5, 2026 /PRNewswire/ -- CellCarta, a leading global CRO laboratory to the biopha... Full story

Yahoo Finance • 13 days ago

1 Volatile Stock with Promising Prospects and 2 We Avoid

1 Volatile Stock with Promising Prospects and 2 We Avoid Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the m... Full story

Yahoo Finance • 19 days ago

1 Growth Stock with All-Star Potential and 2 We Find Risky

1 Growth Stock with All-Star Potential and 2 We Find Risky Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022... Full story

Yahoo Finance • 25 days ago

3 Large-Cap Stocks for Long-Term Investors

3 Large-Cap Stocks for Long-Term Investors Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for... Full story

Yahoo Finance • 28 days ago

1 S&P 500 Stock Worth Your Attention and 2 We Avoid

1 S&P 500 Stock Worth Your Attention and 2 We Avoid The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn't mean every stock is worth owning. Some companies face significant challenges, whether it's stagna... Full story

Yahoo Finance • last month

Waters (WAT) Raised Guidance, Is The Stock Still Cheap?

Waters (WAT) stock is back in focus after the company reported Q2 2026 adjusted earnings of $3.05 per share and raised its full year guidance for organic revenue growth and adjusted earnings. At a share price of $413.56, Waters has posted... Full story

Yahoo Finance • last month

Why Is Waters (WAT) Up 3.1% Since Last Earnings Report?

It has been about a month since the last earnings report for Waters (WAT). Shares have added about 3.1% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is... Full story

Yahoo Finance • 2 months ago

Waters upgraded at Piper Sandler on strong replacement cycle

[Microscope] nicolas_/E+ via Getty Images Waters Corp. (WAT [https://seekingalpha.com/symbol/WAT]) up 1.8% in Thursday's trading, touching a 52-week intraday high of $426.22, as Piper Sandler upgraded the provider of analytical workflow s... Full story

Yahoo Finance • 2 months ago

QIAGEN Appoints Jonathan M. Pratt as Chief Executive Officer

Jon Pratt brings more than 25 years of leadership experience, most recently as CEO of Filtration Group and previously at Waters, Beckman Coulter Life Sciences and Pall To assume CEO role on September 1, 2026, succeeding Thierry Bernard QIA... Full story

Yahoo Finance • 3 months ago

1 S&P 500 Stock to Consider Right Now and 2 That Underwhelm

1 S&P 500 Stock to Consider Right Now and 2 That Underwhelm While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financial... Full story

Yahoo Finance • 3 months ago

Stock index futures fall as tensions rise in Middle East

[Wall street and Broadway road sign in New York City] Stock index futures were lower before the opening bell on Monday as tensions in the Middle East intensified after Washington and Tehran exchanged fresh military strikes. Nasdaq 100 fu... Full story

Yahoo Finance • 3 months ago

Q1 Earnings Roundup: Mettler-Toledo (NYSE:MTD) And The Rest Of The Research Tools & Consumables Segment

Q1 Earnings Roundup: Mettler-Toledo (NYSE:MTD) And The Rest Of The Research Tools & Consumables Segment The end of the earnings season is always a good time to take a step back and see who shined (and who didn't). Let's take a look at how... Full story

Yahoo Finance • 3 months ago

2 Large-Cap Stocks to Keep an Eye On and 1 We Ignore

2 Large-Cap Stocks to Keep an Eye On and 1 We Ignore Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder... Full story

Yahoo Finance • 4 months ago

Global Laboratory Equipment Services Market Size/Share Worth USD 62.83 Billion by 2035 at a 8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Laboratory Equipment Services Market size & share revenue was valued at approximately... Full story

Yahoo Finance • 4 months ago

Waters Corporation (WAT): Buy, Sell, or Hold Post Q1 Earnings?

Waters Corporation (WAT): Buy, Sell, or Hold Post Q1 Earnings? Over the last six months, Waters Corporation's shares have sunk to $357.08, producing a disappointing 7.2% loss - a stark contrast to the S&P 500's 7.8% gain. This may have in... Full story

Yahoo Finance • 4 months ago

Trump bought these health care stocks in 2026; should you?

President Donald Trump has been trading health care stocks unusually frequently in 2026. Across the first three months of the year, his accounts ran 377 separate health care trades, a mix of buys and sells, worth at least $13 million and... Full story

Yahoo Finance • 4 months ago

Waters Launches New Tools As Investors Weigh Biologics And Battery Upside

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Waters Corporation (NYSE:WAT) has launched new analytical instrument platforms and workflow solu... Full story

Yahoo Finance • 4 months ago

1 Healthcare Stock to Consider Right Now and 2 We Brush Off

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, which has supported the industry’s returns lately - over the past six... Full story

Yahoo Finance • 4 months ago

1 Growth Stock with All-Star Potential and 2 We Question

Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle. The risks that can come from buying these asse... Full story

Yahoo Finance • 4 months ago

June 2026's Top Stocks Estimated Below Intrinsic Value

In the last week, the United States market has stayed flat, yet it has experienced a significant 26% increase over the past year with earnings forecasted to grow by 16% annually. In such a robust environment, identifying stocks that are es... Full story